(1387–1416) RA – Diagnosis, Manifestations, and Outcomes Poster III

Poster abstract session.

Presentations:

• 1:00 PM – 3:00 PM Eastern Time

  Real-World Utilization of Adalimumab Biosimilar (ABP 501) in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis in Europe
  

  Abstract Poster Presenter: Ran Jin, PhD – Amgen Inc.
• 1:00 PM – 3:00 PM Eastern Time

  Updating and Validating the Rheumatic Disease Comorbidity Index to Incorporate ICD-10 Diagnostic Codes
  

  Abstract Poster Presenter: Anthony Dolomisiewicz, MD – University of Nebraska Medical Center
• 1:00 PM – 3:00 PM Eastern Time

  The New Serum Synovial Biochemical Marker HELIX-III Predicts Radiological Progression in Early Arthritis Independently of Usual Risk Factors
  

  Abstract Poster Presenter: Patrick Garnero, PhD, DSc – INSERM
• 1:00 PM – 3:00 PM Eastern Time

  Distinct Patterns of Multimorbidity Are Associated with Longitudinal Disease Activity and Functional Status in a Multicenter, Prospective Rheumatoid Arthritis Cohort
  

  Abstract Poster Presenter: Sarah Dutt, -None- – University of Nebraska Medical Center
• 1:00 PM – 3:00 PM Eastern Time

  Inadequate Cardiovascular Disease Risk Screening and Preventative Treatment in Patients with Rheumatoid Arthritis
  

  Abstract Poster Presenter: Tooba Munawar, MD – Upstate Medical University
• 1:00 PM – 3:00 PM Eastern Time

  Comparing Data on Rheumatoid Arthritis (RA) Disease Status Using Patient Reported Outcome Measures (PROMS) RAID/RAPID-3/Self-Reported DAS28 in Remote Electronic Monitoring During the COVID-19 Pandemic with Face-To-Face Clinical Evaluation (DAS28-CRP) Performed Pre-Pandemic
  

  Abstract Poster Presenter: Maria Mirza, MBBS, MRCP – Oxford University Hospital
• 1:00 PM – 3:00 PM Eastern Time

  Lung Involvement in Early Rheumatoid Arthritis, Interim Analysis of the FINDRA Prospective Study
  

  Abstract Poster Presenter: Marie Doyen, MD – Cliniques universitaires Saint-Luc
• 1:00 PM – 3:00 PM Eastern Time

  Identification of Joint Locations in an Early Rheumatoid Arthritis Cohort as a Characteristic of Disease Severity: DATA from the ERA-UCLouvain Brussels Cohort
  

  Abstract Poster Presenter: Laura Bricman, MD – Cliniques universitaires Saint Luc Woluwe
• 1:00 PM – 3:00 PM Eastern Time

  Comparative Safety of Janus Kinase Inhibitors and Tumor Necrosis Factor Inhibitors in Patients Undergoing Treatment for Rheumatoid Arthritis
  

  Abstract Poster Presenter: Yao-fan Fang, MD – Chang-Gung memorial hospital
• 1:00 PM – 3:00 PM Eastern Time

  Risk of Hospitalized Infections in Older Elderly Rheumatoid Arthritis Patients Treated with Biological/Targeted Synthetic DMARDs: Evaluation Using Data from a Japanese Claims Database
  

  Abstract Poster Presenter: Masayoshi Harigai, MD, PhD – Tokyo Women's Medical University
• 1:00 PM – 3:00 PM Eastern Time

  The Impact of Disease Activity on Patient-Reported Cognitive Dysfunction in Rheumatoid Arthritis
  

  Abstract Poster Presenter: Ozlem Pala, MD, MPH – University of Miami
• 1:00 PM – 3:00 PM Eastern Time

  WITHDRAWN
• 1:00 PM – 3:00 PM Eastern Time

  Inflammatory Arthritis Genetic Risk Factors to Predict Treatment Patterns in Rheumatoid Arthritis
  

  Abstract Poster Presenter: Gregory McDermott, MD – Brigham and Women's Hospital
• 1:00 PM – 3:00 PM Eastern Time

  Machine Learning Identifies Molecular Phenotypes That Predict Incident Cardiovascular Disease in Patients with Rheumatoid Arthritis
  

  Abstract Poster Presenter: Tate Johnson, MD – University of Nebraska Medical Center
• 1:00 PM – 3:00 PM Eastern Time

  Relationship Between Disease Activity and Adverse Events of Interest in Patients with RA on Tofacitinib or TNF Inhibitors: Post Hoc Analysis of a Phase 3b/4 Randomized Safety Study
  

  Abstract Poster Presenter: George A. Karpouzas, MD – Harbor-UCLA Medical Center
• 1:00 PM – 3:00 PM Eastern Time

  Late Onset Rheumatoid Arthritis Has a Similar Remission Rate as Younger Onset Rheumatoid Arthritis: Results from an Ontario Rheumatoid Arthritis Registry
  

  Abstract Poster Presenter: Claire Bombardier, MD, FRCPC – University of Toronto - Toronto
• 1:00 PM – 3:00 PM Eastern Time

  Herpes Zoster in Rheumatoid Arthritis: Prospective Single University Center Study
  

  Abstract Poster Presenter: Lucia Cristina Dominguez Casas, MD – Hospital Universtario San Agustin
• 1:00 PM – 3:00 PM Eastern Time

  Machine Learning Model to Accurately Identify Rheumatoid Arthritis Patients Using Raw Electronic Health Record Data
  

  Abstract Poster Presenter: Vinit Gilvaz, MD – Brown University
• 1:00 PM – 3:00 PM Eastern Time

  In Contrast to Anti-CCP, Then MMP Degraded and Citrullinated Vimentin (VICM) Is Both a Diagnostic and Treatment Response Biomarker
  

  Abstract Poster Presenter: Anne-Christine Bay-Jensen, PhD, MSc – Nordic Bioscience
• 1:00 PM – 3:00 PM Eastern Time

  Integrative Multi-omic Phenotyping in Blood Identifies Molecular Signatures and Candidate Biomarkers of ACPA-negative Rheumatoid Arthritis
  

  Abstract Poster Presenter: Benjamin Hur, PhD – Mayo Clinic
• 1:00 PM – 3:00 PM Eastern Time

  Longitudinal Lipid Profile and NT-proBNP Changes from Pre-clinical to Established Rheumatoid Arthritis: A 12 Years Follow up Explorative Study
  

  Abstract Poster Presenter: Reinder Raadsen, MD – Reade
• 1:00 PM – 3:00 PM Eastern Time

  In RA Patients Without Prevalent CVD, Incident CVD Is Only Associated with Traditional Risk Factors: A 20-year Follow up in the CARRÉ Cohort Study
  

  Abstract Poster Presenter: Reinder Raadsen, MD – Reade
• 1:00 PM – 3:00 PM Eastern Time

  Impact of a Hybrid Medical Care Model in the Rheumatoid Arthritis Patient-Reported Outcomes: A Non-inferiority Crossover Randomized Study
  

  Abstract Poster Presenter: Guillermo Guaracha Basañez, MD – Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán"
• 1:00 PM – 3:00 PM Eastern Time

  Subclinical Atherosclerosis Is Not Related with Acid Uric in Rheumatoid Arthritis: Study of 1005 Patients of a Single University Hospital
  

  Abstract Poster Presenter: Fabricio Benavides, MD РHospital Universitario Marqu̩s de Valdecilla
• 1:00 PM – 3:00 PM Eastern Time

  Predictors of Achieving Clinical Remission in ACPA-positive RA-patients Treated with Abatacept and Methotrexate or Methotrexate Monotherapy
  

  Abstract Poster Presenter: Marloes Verstappen, MD – Leiden University Medical Center
• 1:00 PM – 3:00 PM Eastern Time

  Coronary Microvascular Dysfunction in Patients with Rheumatoid Arthritis and Diabetes Mellitus: A Cross-sectional Study with 13NH3 Myocardial PET/CT
  

  Abstract Poster Presenter: Bas Dijkshoorn, MD, MSc – Reade
• 1:00 PM – 3:00 PM Eastern Time

  WITHDRAWN
• 1:00 PM – 3:00 PM Eastern Time

  2022 Revision of the ACR/EULAR Remission Criteria for Rheumatoid Arthritis
  

  Abstract Poster Presenter: Paul Studenic, MD, PhD – Medical University of Vienna
• 1:00 PM – 3:00 PM Eastern Time

  Different Bioactive Lipid Profile Predicts Response to TNF or IL6 Inhibitors in Rheumatoid Arthritis: Result of the CorEvitas CERTAIN Comparative Effectiveness Study
  

  Abstract Poster Presenter: Monica Guma, MD, PhD – UCSD
• 1:00 PM – 3:00 PM Eastern Time

  Bioactive Lipid Profiling Can Identify Dynamic Biomarkers in Response to Biologic Therapy Result of the CorEvitas CERTAIN Comparative Effectiveness Study
  

  Abstract Poster Presenter: Monica Guma, MD, PhD – UCSD